-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 20202020-11-03
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF“SAXAGLIPTIN TABLETS”2020-10-30
-
VOLUNTARY ANNOUNCEMENT - BIOLOGICS LICENSE APPLICATION OF“INEBILIZUMAB INJECTIONS”ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2020-10-14
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 20202020-10-06
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 20202020-09-03
-
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 20202020-08-26
-
DATE OF BOARD MEETING2020-08-14
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 20202020-08-07
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "EMPAGLIFLOZIN TABLETS"2020-07-31
-
INSIDE INFORMATION - LICENSE AGREEMENT WITH EQRX2020-07-23
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 20202020-07-06
-
VOLUNTARY ANNOUNCEMENT - DRUG REGISTRATION APPROVAL OF "PALIPERIDONE EXTENDED-RELEASE TABLETS"2020-06-22